FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) by Cosette Pharmaceuticals, Inc., updating its labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Welchol (colesevelam hydrochloride)

Snippet

SUPPL AP for WELCHOL (COLESEVELAM HYDROCHLORIDE)